EUVIMEDEUVIMED entdecken
Crossref

Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway

Tomoyo Yoshimori, Masashi Kawami, Yuta Kumagai, Sorahito Futatsugi, Ryoko Yumoto, Yasuo Uchida, Mikihisa Takano

The International Journal of Biochemistry & Cell Biology · 2024-07 · 172 · 106601

DOI: 10.1016/j.biocel.2024.106601 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Biochemistry & Cell Biology, 2024-07. Verfasst von Tomoyo Yoshimori und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-0037, Japan. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Benzimidazoles, Cyclin-Dependent Kinase 4, Aminopyridines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abemaciclib (ABM), a cyclin-dependent kinase 4/6 inhibitor, shows pharmacological effects in cell cycle arrest. Epithelial-mesenchymal transition is an important cellular event associated with pathophysiological states such as organ fibrosis and cancer progression. In the present study, we evaluated the contribution of factors associated with cell cycle arrest to ABM-induced epithelial-mesenchymal transition. Treatment with 0.6 µM ABM induced both cell cycle arrest and epithelial-mesenchymal transition-related phenotypic changes. Interestingly, the knockdown of cyclin-dependent kinase 4/6, pharmacological targets of ABM or cyclin D1, which forms complexes with cyclin-dependent kinase 4/6, resulted in cell cycle arrest at the G1-phase and induction of epithelial-mesenchymal transition, indicating that downregulation of cyclin-dependent kinase 4/6-cyclin D1 complexes would mimic ABM. In contrast, knockdown of the Rb protein, which is phosphorylated by cyclin-dependent kinase 4/6, had no effect on the expression level of α-smooth muscle actin, an epithelial-mesenchymal transition marker. Furthermore, ABM-induced epithelial-mesenchymal transition was not affected by Rb knockdown, suggesting that Rb is not involved in the transition process. Our study is the first to suggest that cyclin-dependent kinase 4/6-cyclin D1 complexes, as pharmacological targets of ABM, may contribute to ABM-induced epithelial-mesenchymal transition, followed by clinical disorders such as organ fibrosis and cancer progression. This study suggests that blocking epithelial-mesenchymal transition might be a promising way to prevent negative side effects caused by a medication (ABM) without affecting its ability to treat the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionBenzimidazolesCyclin-Dependent Kinase 4AminopyridinesCyclin-Dependent Kinase 6HumansCell Cycle CheckpointsCyclin D1

Stichwörter der Autor:innen

Cell Cycle arrestCyclin D1Cyclin-dependent kinase 4/6Epithelial-mesenchymal transitionRb proteinabemaciclib

Substanzen

abemaciclibBenzimidazolesCyclin-Dependent Kinase 4AminopyridinesCyclin-Dependent Kinase 6CDK4 protein, humanCyclin D1CDK6 protein, human

Autor:innen und Institutionen

  • Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-0037, Japan.
  • Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-0037, Japan. Electronic address: ma-kawami@hiroshima-u.ac.jp.
  • Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-0037, Japan. Electronic address: yuchida@hiroshima-u.ac.jp.
  • Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science

Zitieren

APA

Yoshimori, T., Kawami, M., Kumagai, Y., Futatsugi, S., Yumoto, R., Uchida, Y., & Takano, M. (2024). Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway. The International Journal of Biochemistry & Cell Biology, 172, 106601. https://doi.org/10.1016/j.biocel.2024.106601

Vancouver

Yoshimori T, Kawami M, Kumagai Y, Futatsugi S, Yumoto R, Uchida Y, et al. Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway. The International Journal of Biochemistry & Cell Biology. 2024;172:106601. doi:10.1016/j.biocel.2024.106601

BibTeX
@article{Yoshimori2024,
  author = {Yoshimori, Tomoyo and Kawami, Masashi and Kumagai, Yuta and Futatsugi, Sorahito and Yumoto, Ryoko and Uchida, Yasuo and Takano, Mikihisa},
  title = {Abemaciclib-induced epithelial-mesenchymal transition mediated by cyclin-dependent kinase 4/6 independent of cell cycle arrest pathway},
  journal = {The International Journal of Biochemistry & Cell Biology},
  year = {2024},
  volume = {172},
  pages = {106601},
  doi = {10.1016/j.biocel.2024.106601}
}
Kostenlos starten →